Learn More
Medchemexpress LLC AT-533 | 908112-37-8 | 98.38% | 410.51 | 5 MG

Supplier: Medchemexpress LLC HY1488775MG
AT-533 is a potent Hsp90 and HSV inhibitor. It suppresses tumor growth and angiogenesis by blocking the HIF-1α/VEGF/VEGFR-2 signaling pathway. Additionally, AT-533 inhibits the activation of downstream pathways such as Akt/mTOR/p70S6K, Erk1/2, and FAK.
- Inhibits tube formation, cell migration, and invasion of human umbilical vein endothelial cells (HUVECs).
- Decreases TNF-α, IL-1β, and IL-6 production in RAW264.7 and BV2 cells induced by HSV-1.
- Shows anti-angiogenic ability in a chorioallantoic membrane (CAM) model.
- Suppresses the expression of HIF-1α/VEGF signaling pathway-related proteins in MDA-MB-231 breast cancer xenografts in mice.
- Subacute toxicity tests showed no mortality, loss of appetite, body weight changes, or adverse reactions in Sprague-Dawley rats.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.